Clinical trials
Phase 2 Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2022 | 1 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 3 |
| Anhui Medical University | 1 |
| Huashan Hospital | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Mei changlin | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| Vincentage Pharma Co., Ltd | 1 |
| Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 13 |
| Essential Hypertension | 2 |
| Atrial Fibrillation | 1 |
| Hyperglycemia | 1 |
| Polycystic Kidney, Autosomal Dominant | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.